Dyne Therapeutics, INC. (DYN) — SC 13G/A Filings
All SC 13G/A filings from Dyne Therapeutics, INC.. Browse 12 SC 13G/A reports with AI-powered summaries and risk analysis.
SC 13G/A Filings (12)
- SC 13G/A Filing — Nov 14, 2024
- SC 13G/A Filing — Nov 14, 2024
- SC 13G/A Filing — Nov 14, 2024
- SC 13G/A Filing — Nov 12, 2024
- SC 13G/A Filing — Nov 8, 2024
- SC 13G/A Filing — Nov 4, 2024
- SC 13G/A Filing — Oct 22, 2024
- SC 13G/A Filing — Feb 14, 2024
- SC 13G/A Filing — Feb 14, 2024
-
MPM BioVentures Trims Dyne Therapeutics Stake to 9.9%
— Feb 12, 2024 Risk: medium
MPM BioVentures 2018, L.P. and its affiliated entities, including MPM Asset Management Investors BV2018 LLC, filed an amended Schedule 13G/A on February 12, 202 -
Atlas Venture Amends Dyne Therapeutics Stake as of Dec 31, 2023
— Feb 9, 2024 Risk: low
Atlas Venture Fund XI, L.P. and its affiliated entities (collectively, "Atlas Venture") filed an amended SC 13G/A on February 9, 2024, indicating a change in th -
Deep Track Capital Maintains 2M Share Stake in Dyne Therapeutics
— Jan 19, 2024
Deep Track Capital, LP, a Delaware-based investment firm, filed an amended SC 13G/A on January 19, 2024, disclosing its beneficial ownership in Dyne Therapeutic
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX